Literature DB >> 31584114

Impact of matrix effects and ionization efficiency in non-quantitative untargeted metabolomics.

Casey A Chamberlain1, Vanessa Y Rubio2, Timothy J Garrett3.   

Abstract

INTRODUCTION: LC-MS-based untargeted metabolomics has become increasingly popular due to the vast amount of information gained in a single analysis. Many studies utilize metabolomics to profile metabolic changes in various representative biofluids, tissues, or other sample types. Most analyses are performed measuring changes in the metabolic pool of a single biological matrix due to an altered phenotype, such as disease versus normal. Measurements in such experiments are typically highly reproducible with little variation due to analytical and technological advancements in mass spectrometry. With the expanded application of metabolomics into various non-analytical scientific disciplines, the emergence of studies comparing the signal intensities of specific analytes across different biological matrices (e.g. plasma vs. urine) is becoming more common, but the matrix effect between sample types is often neglected. Additionally, the practice of comparing the signal intensities of different analytes and correlating to relative abundance is also increasingly prevalent, but the response ratio between analytes due to differences in ionization efficiency is not always accounted for in data analysis. This report serves to communicate and raise awareness of these two well-recognized issues to prevent improper data interpretation in the field of metabolomics.
OBJECTIVES: We demonstrate the impact of matrix effects and ionization efficiency with labeled analytical standards in human plasma, serum, and urine and describe how the direct comparison of non-quantitative signal intensities between biofluids, as well as between different analytes in the same biofluid, in untargeted metabolomics is inaccurate without proper response corrections.
METHODS: Human plasma, serum, and urine (n = 4 technical replicates per biofluid) were spiked with a panel of labeled internal standards all at identical concentrations, simultaneously extracted, and analyzed by UHPLC-HRMS. Signal intensities were compared for demonstration of the impact of matrix effects in untargeted metabolomics. A neat mixture of two co-eluting, structurally-similar labeled standards at the same concentration was also analyzed to demonstrate the effect of ionization efficiency on signal intensity.
RESULTS: Despite being spiked at identical concentrations, labeled standards we examined in this study showed significant differences in their signal intensities between biofluids, as well as from each other in the same biofluid, due to matrix effects. Co-eluting standards were also found to yield significantly different signal intensities at identical concentrations due to differences in ionization efficiency.
CONCLUSIONS: Due to the presence of matrix effects in untargeted, non-quantitative metabolomics, the signal intensity of any single analyte cannot be directly compared to the signal intensity of that same analyte (or any other analyte) between any two different matrices. Due to differences in ionization efficiency, the signal intensity of any single analyte cannot be directly compared to the signal intensity of any other analyte, even in the same matrix.

Entities:  

Keywords:  Ionization efficiency; LC–MS; Mass spectrometry; Matrix effect; Metabolomics

Mesh:

Substances:

Year:  2019        PMID: 31584114     DOI: 10.1007/s11306-019-1597-z

Source DB:  PubMed          Journal:  Metabolomics        ISSN: 1573-3882            Impact factor:   4.290


  20 in total

1.  Matrix effect in quantitative LC/MS/MS analyses of biological fluids: a method for determination of finasteride in human plasma at picogram per milliliter concentrations.

Authors:  B K Matuszewski; M L Constanzer; C M Chavez-Eng
Journal:  Anal Chem       Date:  1998-03-01       Impact factor: 6.986

Review 2.  Dark matter in host-microbiome metabolomics: Tackling the unknowns-A review.

Authors:  B Y Loulou Peisl; Emma L Schymanski; Paul Wilmes
Journal:  Anal Chim Acta       Date:  2017-12-30       Impact factor: 6.558

3.  KEGG-PATH: Kyoto encyclopedia of genes and genomes-based pathway analysis using a path analysis model.

Authors:  Junli Du; Zhifa Yuan; Ziwei Ma; Jiuzhou Song; Xiaoli Xie; Yulin Chen
Journal:  Mol Biosyst       Date:  2014-07-29

4.  Mass spectrometry in untargeted liquid chromatography/mass spectrometry metabolomics: Electrospray ionisation parameters and global coverage of the metabolome.

Authors:  Fidele Tugizimana; Paul A Steenkamp; Lizelle A Piater; Ian A Dubery
Journal:  Rapid Commun Mass Spectrom       Date:  2018-01-30       Impact factor: 2.419

5.  Matrix effects and application of matrix effect factor.

Authors:  Wanlong Zhou; Shuang Yang; Perry G Wang
Journal:  Bioanalysis       Date:  2017-11-24       Impact factor: 2.681

6.  Systematic evaluation of supported liquid extraction in reducing matrix effect and improving extraction efficiency in LC-MS/MS based bioanalysis for 10 model pharmaceutical compounds.

Authors:  Hongliang Jiang; Huachuan Cao; Yang Zhang; Douglas M Fast
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2012-02-23       Impact factor: 3.205

7.  METLIN: A Technology Platform for Identifying Knowns and Unknowns.

Authors:  Carlos Guijas; J Rafael Montenegro-Burke; Xavier Domingo-Almenara; Amelia Palermo; Benedikt Warth; Gerrit Hermann; Gunda Koellensperger; Tao Huan; Winnie Uritboonthai; Aries E Aisporna; Dennis W Wolan; Mary E Spilker; H Paul Benton; Gary Siuzdak
Journal:  Anal Chem       Date:  2018-02-09       Impact factor: 6.986

Review 8.  Metabolomics for the masses: The future of metabolomics in a personalized world.

Authors:  Drupad K Trivedi; Katherine A Hollywood; Royston Goodacre
Journal:  New Horiz Transl Med       Date:  2017-03

9.  HMDB 4.0: the human metabolome database for 2018.

Authors:  David S Wishart; Yannick Djoumbou Feunang; Ana Marcu; An Chi Guo; Kevin Liang; Rosa Vázquez-Fresno; Tanvir Sajed; Daniel Johnson; Carin Li; Naama Karu; Zinat Sayeeda; Elvis Lo; Nazanin Assempour; Mark Berjanskii; Sandeep Singhal; David Arndt; Yonjie Liang; Hasan Badran; Jason Grant; Arnau Serra-Cayuela; Yifeng Liu; Rupa Mandal; Vanessa Neveu; Allison Pon; Craig Knox; Michael Wilson; Claudine Manach; Augustin Scalbert
Journal:  Nucleic Acids Res       Date:  2018-01-04       Impact factor: 16.971

10.  Improved batch correction in untargeted MS-based metabolomics.

Authors:  Ron Wehrens; Jos A Hageman; Fred van Eeuwijk; Rik Kooke; Pádraic J Flood; Erik Wijnker; Joost J B Keurentjes; Arjen Lommen; Henriëtte D L M van Eekelen; Robert D Hall; Roland Mumm; Ric C H de Vos
Journal:  Metabolomics       Date:  2016-03-18       Impact factor: 4.290

View more
  6 in total

1.  Development of cVSSI-APCI for the Improvement of Ion Suppression and Matrix Effects in Complex Mixtures.

Authors:  Madison E Pursell; Daud Sharif; Anthony DeBastiani; Chong Li; Sandra Majuta; Peng Li; Stephen J Valentine
Journal:  Anal Chem       Date:  2022-06-21       Impact factor: 8.008

2.  High-Precision Automated Workflow for Urinary Untargeted Metabolomic Epidemiology.

Authors:  Isabel Meister; Pei Zhang; Anirban Sinha; C Magnus Sköld; Åsa M Wheelock; Takashi Izumi; Romanas Chaleckis; Craig E Wheelock
Journal:  Anal Chem       Date:  2021-03-19       Impact factor: 6.986

3.  Untargeted Metabolic Profiling of 4-Fluoro-Furanylfentanyl and Isobutyrylfentanyl in Mouse Hepatocytes and Urine by Means of LC-HRMS.

Authors:  Camilla Montesano; Flaminia Vincenti; Federico Fanti; Matteo Marti; Sabrine Bilel; Anna Rita Togna; Adolfo Gregori; Fabiana Di Rosa; Manuel Sergi
Journal:  Metabolites       Date:  2021-02-10

4.  Comparison of dried blood spot and plasma sampling for untargeted metabolomics.

Authors:  Nicole H Tobin; Aisling Murphy; Fan Li; Sean S Brummel; Taha E Taha; Friday Saidi; Maxie Owor; Avy Violari; Dhayendre Moodley; Benjamin Chi; Kelli D Goodman; Brian Koos; Grace M Aldrovandi
Journal:  Metabolomics       Date:  2021-06-23       Impact factor: 4.747

5.  Simultaneous measurement of tadehaginoside and its principal metabolite in rats by HPLC-MS/MS and its application in pharmacokinetics and tissue distribution study.

Authors:  Cai-Yun Zhang; Ya-Ting Lu; Yin-Feng Tan; Qi-Bing Liu; Lin Dong; Ning Ma; Wei-Ying Lu; Zhi-Heng Su; Xiao-Po Zhang
Journal:  Pharm Biol       Date:  2021-12       Impact factor: 3.503

6.  A Novel Propidium Monoazide-Based PCR Assay Can Measure Viable Uropathogenic E. coli In Vitro and In Vivo.

Authors:  Albert S Lee; Olivia K Lamanna; Kenji Ishida; Elaise Hill; Andrew Nguyen; Michael H Hsieh
Journal:  Front Cell Infect Microbiol       Date:  2022-02-01       Impact factor: 5.293

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.